BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30118782)

  • 1. Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia.
    Lu JY; Tiwari AK; Zai GC; Rastogi A; Shaikh SA; Müller DJ; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Wong AHC; Kennedy JL; Zai CC
    Neurosci Lett; 2018 Nov; 686():17-22. PubMed ID: 30118782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study between the neurexin-1 gene and tardive dyskinesia.
    Lanning R; Lett TA; Tiwari AK; Brandl EJ; de Luca V; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Remington G; Kennedy JL; Zai CC
    Hum Psychopharmacol; 2017 Jan; 32(1):. PubMed ID: 28120489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of rs1076560 (DRD2) and rs4680 (COMT) on tardive dyskinesia and cognition in schizophrenia subjects.
    Punchaichira TJ; Kukshal P; Bhatia T; Deshpande SN; Thelma BK
    Psychiatr Genet; 2020 Oct; 30(5):125-135. PubMed ID: 32931693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.
    Zai CC; Tiwari AK; Chowdhury NI; Yilmaz Z; de Luca V; Müller DJ; Potkin SG; Lieberman JA; Meltzer HY; Voineskos AN; Remington G; Kennedy JL
    World J Biol Psychiatry; 2019 Jan; 20(1):91-95. PubMed ID: 28394697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
    Hui L; Han M; Yin GZ; Zhang Y; Huang XF; Qian ZK; Gu WG; Gu XC; Zhu XM; Soares JC; Ning Y; Zheng Y; Du XD; Zhang XY
    Schizophr Res; 2017 Apr; 182():104-109. PubMed ID: 27776953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of tardive dyskinesia: an updated review of the literature.
    Lanning RK; Zai CC; Müller DJ
    Pharmacogenomics; 2016 Aug; 17(12):1339-51. PubMed ID: 27469238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.
    Zai CC; Tiwari AK; Mazzoco M; de Luca V; Müller DJ; Shaikh SA; Lohoff FW; Freeman N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL
    J Psychiatr Res; 2013 Nov; 47(11):1760-5. PubMed ID: 24018103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.
    Souza RP; Remington G; Meltzer HY; Lieberman JA; Kennedy JL; Wong AH
    Int Clin Psychopharmacol; 2010 Sep; 25(5):264-9. PubMed ID: 20436352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia.
    Maes MS; Lu JY; Tiwari AK; Freeman N; de Luca V; Müller DJ; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL; Zai CC
    Drug Dev Res; 2021 Aug; 82(5):678-684. PubMed ID: 32394511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between polymorphisms in the cannabinoid receptor 1 gene, cognitive impairments and tardive dyskinesia in a Chinese population with schizophrenia.
    Lu C; Li S; Li Y; Zhang X; Chi J; Jiang Q; Ma Y; Shi X; Wang L; Li J
    Brain Res; 2023 Dec; 1821():148579. PubMed ID: 37739333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.
    Zai CC; Hwang RW; De Luca V; Müller DJ; King N; Zai GC; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):639-51. PubMed ID: 16959057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia.
    Segman R; Neeman T; Heresco-Levy U; Finkel B; Karagichev L; Schlafman M; Dorevitch A; Yakir A; Lerner A; Shelevoy A; Lerer B
    Mol Psychiatry; 1999 May; 4(3):247-53. PubMed ID: 10395214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.
    Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ
    Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia.
    Loonen AJ; Wilffert B; Ivanova SA
    Pharmacogenomics; 2019 Nov; 20(17):1199-1223. PubMed ID: 31686592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
    Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
    Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver enzyme
    Lu JY; Tiwari AK; Freeman N; Zai GC; Luca V; Müller DJ; Tampakeras M; Herbert D; Emmerson H; Cheema SY; King N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL; Zai CC
    Pharmacogenomics; 2020 Oct; 21(15):1065-1072. PubMed ID: 32969762
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.
    Novak G; Gallo A; Zai CC; Meltzer HY; Lieberman JA; Potkin SG; Voineskos AN; Remington G; Kennedy JL; Levesque D; Le Foll B
    Psychiatr Genet; 2010 Feb; 20(1):39-43. PubMed ID: 20010315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia.
    Lai IC; Liao DL; Bai YM; Lin CC; Yu SC; Chen JY; Wang YC
    Neuropsychobiology; 2002; 46(4):173-5. PubMed ID: 12566932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians.
    Souza RP; Remington G; Chowdhury NI; Lau MK; Voineskos AN; Lieberman JA; Meltzer HY; Kennedy JL
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):688-94. PubMed ID: 20605420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.